KL
Kalaris Therapeutics Inc (KLRS)
NASDAQ·Healthcare·Biotechnology
$4.35
-0.23%
Mkt Cap $187.02M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$18.25
Range $14.00 – $23.00
Implied Upside
+319.5%
Consensus $18.25 vs current $4.35
NASDAQ·Healthcare·Biotechnology
$4.35
-0.23%
Mkt Cap $187.02M
No recent rating data.
Price Target (5 analysts)
$18.25
Range $14.00 – $23.00
+319.5%
Consensus $18.25 vs current $4.35